Neuroendocrine and Adrenal Tumors

NCT ID: NCT04432532

Last Updated: 2025-02-10

Basic Information

• Recruitment Status: WITHDRAWN
• Study Classification: OBSERVATIONAL
• Study Start Date: 2025-12-01
• Study Completion Date: 2028-01-01

Brief Summary

This is a prospective study of rare neuroendocrine and adrenal tumors. Subjects will be enrolled via informed consent, and blood and/or saliva and tissue will be collected. This is designed to work in conjunction with IRB#831990 which is a retrospective protocol. The University of Pennsylvania will be a contributing site with the University of Michigan as the coordinating site for the A5 alliance, a multi-institutional collaborative designed to study neuroendocrine and adrenal tumors.

Conditions

Neuroendocrine Tumors; Adrenal Tumor

Study Design

• Observational Model Type: CASE_CONTROL
• Study Time Perspective: PROSPECTIVE

Study Groups

Neuroendocrine Tumor

No intervention

Intervention Type: OTHER

There are no interventions

Adrenal Tumor

No intervention

Intervention Type: OTHER

There are no interventions

Interventions

No intervention

There are no interventions

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• diagnosed with neuroendocrine and/or an adrenal tumor

Exclusion Criteria

• pregnant women
• prisoners
• people under the age of 18

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 90 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University of Pennsylvania

OTHER

Sponsor Role: lead

Responsible Party

Heather Wachtel, MD

Assistant Professor of Surgery

Responsibility Role: PRINCIPAL_INVESTIGATOR

Other Identifiers

832475

Identifier Type: -

Identifier Source: org_study_id